101 related articles for article (PubMed ID: 15336730)
1. Analysis of KIT (CD117) expression in gallbladder carcinomas by tissue microarray.
Langner C; Lemmerer M; Kornprat P
Eur J Surg Oncol; 2004 Oct; 30(8):847-50. PubMed ID: 15336730
[TBL] [Abstract][Full Text] [Related]
2. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
Zigeuner R; Ratschek M; Langner C
BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer.
Tanaka S; Tanaka H; Yamamoto T; Shuto T; Takemura S; Hai S; Sakabe K; Uenishi T; Hirohashi K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):228-34. PubMed ID: 16708300
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma.
Reed J; Ouban A; Schickor FK; Muraca P; Yeatman T; Coppola D
Clin Colorectal Cancer; 2002 Aug; 2(2):119-22. PubMed ID: 12453327
[TBL] [Abstract][Full Text] [Related]
5. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
Kornprat P; Rehak P; Rüschoff J; Langner C
J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
[TBL] [Abstract][Full Text] [Related]
7. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
[TBL] [Abstract][Full Text] [Related]
8. The presence and significance of iron in neoplasia of the colorectum.
Labropoulou EP; Datsis A; Kekelos S; Rogdakis A; Katsiki E; Labropoulou CM; Spiliotis J; Christopoulou A
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s211-3. PubMed ID: 15655626
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Brustmann H
Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
[TBL] [Abstract][Full Text] [Related]
11. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis.
Naeem M; Dahiya M; Clark JI; Creech SD; Alkan S
Hum Pathol; 2002 Dec; 33(12):1182-7. PubMed ID: 12514786
[TBL] [Abstract][Full Text] [Related]
12. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.
Diniz G; Aktas S; Ortac R; Tunakan M; Unlu I; Vergin C
Pathol Res Pract; 2006; 202(9):671-7. PubMed ID: 16860492
[TBL] [Abstract][Full Text] [Related]
13. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
Slomovitz BM; Broaddus RR; Schmandt R; Wu W; Oh JC; Ramondetta LM; Burke TW; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Oct; 95(1):32-6. PubMed ID: 15385107
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
15. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
17. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma.
Mino M; Pilch BZ; Faquin WC
Mod Pathol; 2003 Dec; 16(12):1224-31. PubMed ID: 14681323
[TBL] [Abstract][Full Text] [Related]
18. CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid.
Aydin O; Yildiz L; Kefeli M; Kandemir B
Pathol Res Pract; 2008; 204(6):359-65. PubMed ID: 18337018
[TBL] [Abstract][Full Text] [Related]
19. Rare expression of KIT (CD117) in lymphomas: a tissue microarray study of 1166 cases.
Zimpfer A; Went P; Tzankov A; Pehrs AC; Lugli A; Maurer R; Terracciano L; Pileri S; Dirnhofer S
Histopathology; 2004 Oct; 45(4):398-404. PubMed ID: 15469479
[TBL] [Abstract][Full Text] [Related]
20. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
